Exploring Cellectar's Cutting-Edge Cancer Treatment and Biotech Challenges | James V Caruso, CEO,Cellectar Biosciences Inc. 00:10:00

Share On Facebook Share On Twitter

Discover the pioneering efforts of a clinical-stage biopharmaceutical company developing targeted cancer treatments through a discussion with its CEO and team, exploring product development, clinical trials, and navigating challenges in the biotech investment landscape.

Recent Videos